AMGN Amgen Inc
Amgen Inc price
-1.66% Past Week
Market Cap
172.25B
Day’s Range
52W Range
Volume (3M)
2.08M
Price-Earnings Ratio
55.23
Revenue
30.74B
Amgen Inc Latest News
About Amgen Inc
Amgen Inc. is a healthcare company that develops and manufactures innovative human therapeutics designed to address health issues such as cancer and cardiovascular diseases. Founded in 1980 and headquartered in Thousand Oaks, California, the company operates worldwide. It trades using the ticker AMGN on the NASDAQ. Add this instrument to your eToro watchlist to stay updated on AMGN price indicators and trends.
Show MoreRobert A. Bradway, MBA
CEO
26.7K
Employees
1980
Founded
Thousand Oaks, California, US
HQ
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
68
Very High
Industry
Avg. 43
75
Environment
64
Social
72
Governance
Business Involvement Flags
GMO
Companies engaged in plant and animal breeding, genetics and genomics, including
animal and plant DNA testing services.
Consensus
Moderate Buy
Price Target
349.92
People Also Bought
- MRK Merck & Co. -2.06%
- GILD Gilead Sciences Inc 0.57%
- MDT.US Medtronic PLC 0.81%
- ABT Abbott Laboratories 2.26%
- TMO Thermo Fisher Scientific Inc 1.49%
AMGN Upcoming events
5
NOV
Earnings Report
Q4 2024
After Market Close